Accuray (ARAY) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.84% |
| Dec 31, 2025 | 17.16% |
| Sep 30, 2025 | 6.61% |
| Jun 30, 2025 | 11.80% |
| Mar 31, 2025 | 59.21% |
| Dec 31, 2024 | -88.24% |
| Sep 30, 2024 | 64.06% |
| Jun 30, 2024 | -46.54% |
| Mar 31, 2024 | -95.75% |
| Dec 31, 2023 | 61.77% |
| Sep 30, 2023 | 62.27% |
| Jun 30, 2023 | 0.77% |
| Mar 31, 2023 | -100.22% |
| Dec 31, 2022 | 8.22% |
| Sep 30, 2022 | 70.56% |
| Jun 30, 2022 | 70.70% |
| Mar 31, 2022 | 69.98% |
| Dec 31, 2021 | 63.82% |
| Sep 30, 2021 | 66.15% |
| Jun 30, 2021 | 68.00% |
| Mar 31, 2021 | 44.40% |
| Dec 31, 2020 | 7.18% |
| Sep 30, 2020 | 10.09% |
| Jun 30, 2020 | 5.65% |
| Mar 31, 2020 | 9.72% |
| Dec 31, 2019 | 55.44% |
| Sep 30, 2019 | 11.93% |
| Jun 30, 2019 | 43.33% |
| Mar 31, 2019 | 58.65% |
| Dec 31, 2018 | 17.93% |
| Sep 30, 2018 | 15.76% |
| Jun 30, 2018 | -1.54% |
| Mar 31, 2018 | 56.68% |
| Dec 31, 2017 | -1.88% |
| Sep 30, 2017 | 6.09% |
| Jun 30, 2017 | 7.84% |
| Mar 31, 2017 | 10.43% |
| Dec 31, 2016 | 22.55% |
| Sep 30, 2016 | 1.05% |
| Jun 30, 2016 | -14.37% |
| Mar 31, 2016 | -4.58% |
| Dec 31, 2015 | -25.76% |
| Sep 30, 2015 | -29.19% |
| Jun 30, 2015 | -25.92% |